Vanmechelen E - Search Results

1

A Practical Guide to Immunoassay Method Validation.

Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S, Kruse N, Kuiperij HB, Kulic L, Lewczuk P, Mollenhauer B, Mroczko B, Parnetti L, Vanmechelen E, Verbeek MM, Winblad B, Zetterberg H, Koel-Simmelink M, Teunissen CE. Andreasson U, et al. Among authors: vanmechelen e. Front Neurol. 2015 Aug 19;6:179. doi: 10.3389/fneur.2015.00179. eCollection 2015. Front Neurol. 2015. PMID: 26347708 Free PMC article.

2

Plasma p-tau181/Aβ_1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ_1-42 and future cognitive decline.

Fowler CJ, Stoops E, Rainey-Smith SR, Vanmechelen E, Vanbrabant J, Dewit N, Mauroo K, Maruff P, Rowe CC, Fripp J, Li QX, Bourgeat P, Collins SJ, Martins RN, Masters CL, Doecke JD. Fowler CJ, et al. Among authors: vanmechelen e. Alzheimers Dement (Amst). 2022 Nov 25;14(1):e12375. doi: 10.1002/dad2.12375. eCollection 2022. Alzheimers Dement (Amst). 2022. PMID: 36447478 Free PMC article.

3

Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders.

Gómez de San José N, Goossens J, Al Shweiki MR, Halbgebauer S, Oeckl P, Steinacker P, Danzer KM, Graf H, Schönfeldt-Lecuona C, Belbin O, Lleó A, Vanmechelen E, Otto M. Gómez de San José N, et al. Among authors: vanmechelen e. J Psychiatr Res. 2022 Dec;156:390-397. doi: 10.1016/j.jpsychires.2022.10.010. Epub 2022 Oct 17. J Psychiatr Res. 2022. PMID: 36323141

4

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

Sjögren M, Davidsson P, Wallin A, Granérus AK, Grundström E, Askmark H, Vanmechelen E, Blennow K. Sjögren M, et al. Among authors: vanmechelen e. Dement Geriatr Cogn Disord. 2002;13(2):112-8. doi: 10.1159/000048642. Dement Geriatr Cogn Disord. 2002. PMID: 11844893

5

Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment.

Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K. Andreasen N, et al. Among authors: vanmechelen e. Acta Neurol Scand Suppl. 2003;179:47-51. doi: 10.1034/j.1600-0404.107.s179.9.x. Acta Neurol Scand Suppl. 2003. PMID: 12603251 Clinical Trial.

6

Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets.

Olsson A, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K. Olsson A, et al. Among authors: vanmechelen e. Dement Geriatr Cogn Disord. 2003;16(2):93-7. doi: 10.1159/000070681. Dement Geriatr Cogn Disord. 2003. PMID: 12784033

7

CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry.

Blennow K, Vanmechelen E. Blennow K, et al. Among authors: vanmechelen e. Brain Res Bull. 2003 Aug 15;61(3):235-42. doi: 10.1016/s0361-9230(03)00086-8. Brain Res Bull. 2003. PMID: 12909293 Review.

8

Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.

Höglund K, Wiklund O, Vanderstichele H, Eikenberg O, Vanmechelen E, Blennow K. Höglund K, et al. Among authors: vanmechelen e. Arch Neurol. 2004 Mar;61(3):333-7. doi: 10.1001/archneur.61.3.333. Arch Neurol. 2004. PMID: 15023808 Clinical Trial.

9

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K. Olsson A, et al. Among authors: vanmechelen e. Clin Chem. 2005 Feb;51(2):336-45. doi: 10.1373/clinchem.2004.039347. Epub 2004 Nov 24. Clin Chem. 2005. PMID: 15563479 Clinical Trial.

10

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann H, Bibl M, Wolf S, Otto M, Reulbach U, Kölsch H, Jessen F, Schröder J, Schönknecht P, Hampel H, Peters O, Weimer E, Perneczky R, Jahn H, Luckhaus C, Lamla U, Supprian T, Maler JM, Wiltfang J. Lewczuk P, et al. Among authors: vanmechelen e. Neurobiol Aging. 2008 Jun;29(6):812-8. doi: 10.1016/j.neurobiolaging.2006.12.010. Epub 2007 Jan 19. Neurobiol Aging. 2008. PMID: 17239996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page